Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: administering the study drugs intravenously: The study drugs and normal saline will be prepared in 5ml coded syringes and presented to anaesthetists who were blinded to study group allo
Sponsors
chettinad hospital and research institute
Eligibility
Inclusion criteria
Inclusion criteria: american society of anaesthesiologist grade 2 patients coming for elective and emergency caesarean section
Exclusion criteria
Exclusion criteria: 1.patient not willing to be in study group 2.patients with allergic reaction to study drug 3.patients undergoing General Anaesthesia 4.patients with hypovolemia 5.Patients with stenotic valve diseases 6. patients with infection at the site of administering spinal anaesthesia 7.Patients with coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevention of shivering post spinal anaesthesia after IV Ketamine 0.2 mg/kg and IV Palanosetron 0.075 mgTimepoint: Baseline , Every 5 Minutes until the end of surgery Every 10 minutes in the PostOperative period for 1 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| to assess any other adverse effects and prevention of postoperative nausea and vomitingTimepoint: Baseline , Every 5 Minutes until the end of surgery Every 10 minutes in the PostOperative period for 1 hour | — |
Countries
India
Contacts
Public ContactMerlin Shalini Ruth
chettinad hospital and research institute
Outcome results
None listed